William Looney: In terms of nation-state actors, can we identify where the pressure points on cybersecurity are coming from?
Mollie Shields-Uehling, SAFE-BioPharma: In biopharma, this is relatively easy to determine. Each year, the R&D industry’s trade organization, PhRMA, submits...
Welcome to In Vivo
Create an account to read this article
Already a subscriber?